KARA TOPKA: Open Payments
NPI 1255707071 · ALTOONA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,436 in 81 payments from 11 companies in 2025. Trend: 2023 $1,251 · 2024 $1,486 · 2025 $1,436
Food & beverage: $1,436
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $421 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $232 |
| Ardelyx, Inc. | 10 | $229 |
| Janssen Biotech, Inc. | 12 | $189 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $95 |
| Madrigal Pharmaceuticals | 2 | $88 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
| Phathom Pharmaceuticals, Inc. | 5 | $47 |
| Ipsen Biopharmaceuticals, Inc | 2 | $40 |
| GENZYME CORPORATION | 1 | $17 |
Products named: RINVOQ, IBSRELA, TREMFYA, ENTYVIO, EOHILIA, XIFAXAN, REZDIFFRA, DUPIXENT.
Industry payments across PA — which companies pay providers there.
